Compare Wegovy and Mounjaro: Which Suits You?
Understanding the Wegovy and Mounjaro Difference in Prescription Weight Loss
The primary wegovy and mounjaro difference lies in their active ingredients and mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, representing a dual incretin approach to weight management. Both are prescription-only medicines designed to support weight loss alongside a reduced-calorie diet and increased physical activity.
When considering the wegovy and mounjaro difference for prescription weight loss, it's essential to understand that both treatments require the same eligibility criteria: BMI ≥30, or BMI ≥27 with weight-related comorbidities such as type 2 diabetes or hypertension. Your prescriber will evaluate your medical history, current medications, and weight loss goals to determine which treatment may be more suitable. Both medications follow dose escalation protocols, starting with lower doses to minimise side effects whilst building tolerance to the therapeutic maintenance dose.
Wegovy and Mounjaro Difference: UK Pricing and Value Comparison
The wegovy and mounjaro difference extends to pricing structures, with both treatments available through EverydayMeds at competitive rates. Wegovy starts at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25. Our bundle options provide convenience for longer treatment periods, such as the Intro Duo (0.25mg & 0.5mg) for £169.99.
Understanding the wegovy and mounjaro difference in prescription weight loss costs helps you plan your treatment budget effectively. Both medications represent significant investments in your health, but the pricing reflects the advanced pharmaceutical technology and extensive clinical development behind each treatment. EverydayMeds offers flexible payment options and bundle deals to make prescription weight loss more accessible, with assured cold-chain storage and next-day delivery included in every order from our GPhC-registered facility.
Clinical Evidence: Wegovy and Mounjaro Difference in Weight Loss Trials
The wegovy and mounjaro difference is supported by distinct clinical trial programmes, each demonstrating significant weight loss potential. Wegovy's STEP trial programme showed that patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
When examining the wegovy and mounjaro difference in prescription weight loss evidence, Mounjaro's SURMOUNT trials demonstrated impressive results with tirzepatide's dual receptor approach. However, we cannot directly compare trial results due to different study designs, patient populations, and endpoints. Both treatments have received MHRA licensing and NICE recommendations based on their individual merit, with clinical evidence cited in publications including Wilding et al., NEJM, 2021 for semaglutide's weight management efficacy.
How Wegovy Works: The GLP-1 Mechanism in Prescription Weight Loss
Understanding how Wegovy functions helps clarify the wegovy and mounjaro difference in prescription weight loss approaches. Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural hormone released by your intestines after eating. This hormone signals to your brain's appetite control centres, reducing hunger sensations and promoting feelings of fullness after smaller meals. The medication may also slow gastric emptying, helping you feel satisfied for longer periods between meals. Additionally, Wegovy can influence food-seeking behaviours and cravings by acting on reward pathways in the brain, potentially reducing the psychological drive to overeat.
Ordering Process: Accessing Wegovy Through EverydayMeds
The wegovy and mounjaro difference becomes less important once you understand our streamlined ordering process for prescription weight loss treatment. Begin with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight loss goals, and lifestyle factors. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate for your circumstances. Once approved, your prescription is prepared in our temperature-controlled facility and dispatched via next-day delivery using specialist cold-chain packaging. Our ongoing support includes dosing guidance, side effect management, and regular check-ins to monitor your progress throughout treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
A key wegovy and mounjaro difference lies in storage requirements and practical usage considerations for prescription weight loss treatment. Wegovy offers superior storage flexibility, remaining stable for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications use pre-filled injection pens - Wegovy utilises Novo Nordisk's FlexTouch pen system, whilst Mounjaro uses Eli Lilly's KwikPen design. Wegovy follows a 5-step dose escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg), with each dose maintained for 4 weeks to optimise tolerance and minimise gastrointestinal side effects before progressing to the next level.
Choosing Between Treatments: Personalised Prescription Weight Loss Approach
The wegovy and mounjaro difference becomes most relevant when considering your individual circumstances and treatment preferences. Some patients may respond better to Wegovy's targeted GLP-1 approach, particularly those with predominantly appetite-driven eating patterns or food cravings. Others might benefit more from Mounjaro's dual receptor mechanism, especially if they have concurrent metabolic concerns or haven't responded optimally to single-incretin therapies previously.
Rather than viewing the wegovy and mounjaro difference as a competitive choice, consider both options as valuable tools in prescription weight loss management. Your EverydayMeds prescriber will evaluate factors including your medical history, previous weight loss attempts, concurrent medications, and personal preferences to recommend the most appropriate treatment. Both medications require commitment to lifestyle modifications and regular monitoring, with the flexibility to switch between treatments if your initial choice doesn't deliver optimal results.
Expert Guidance: Making the Right Prescription Weight Loss Choice
Understanding the wegovy and mounjaro difference is just the beginning of your prescription weight loss journey with EverydayMeds. Our clinical team combines pharmaceutical expertise with personalised patient care, ensuring you receive the treatment most likely to support your long-term weight management goals. Both Wegovy and Mounjaro are available through our secure online platform, with comprehensive support materials, side effect guidance, and ongoing monitoring included in every prescription. Whether you choose Wegovy's proven GLP-1 approach or Mounjaro's innovative dual mechanism, you'll benefit from our GPhC-registered pharmacy standards (#9012878) and commitment to safe, effective weight loss treatment. Start your assessment today using discount code FIRST40 for new customers, and discover which prescription weight loss solution can transform your health journey at https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
